Even after the bad news dump webinar, still no buying on market by Starpharma board members. This is such a bad look. Why would any investor buy SPL when the CEO is not buying (even near historical record lows.)
CEO - CM (appointed Jan 2024) owns zero Starpharma shares.
Director - David McIntyre (appointed March 2020) owns $1870 worth of Starpharma shares.
P.S. Owning $1870 worth of shares after 4 years in the job is a complete insult to shareholders.
Even after the bad news dump webinar, still no buying on market...
-
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add SPL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
10.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $43.82M | |||
| Open | High | Low | Value | Volume |
| 10.5¢ | 10.5¢ | 10.0¢ | $16.81K | 161.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 604928 | 10.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 10.5¢ | 65132 | 1 |
View Market Depth
| Last trade - 16.10pm 20/09/2024 (20 minute delay) ? |
| SPL (ASX) Chart |